Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis

American Journal of Pathology

Volumn 170, Issue 1, 2007, Pages 65-74

  Chua, Felix ^a   Dunsmore, Sarah E ^a,d   Clingen, Peter H ^b   Mutsaers, Steven E ^a   Shapiro, Steven D ^c   Segal, Anthony W ^a   Roes, Jürgen ^a   Laurent, Geoffrey J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CANCER GROWTH FACTOR; LEUKOCYTE ELASTASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DNA DAMAGE; DRUG EFFECT; DRUG RESISTANCE; GENETICS; IMMUNOLOGY; LUNG LAVAGE; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; DNA DAMAGE; DRUG RESISTANCE; LEUKOCYTE ELASTASE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PULMONARY FIBROSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33847051344     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060352     Document Type: Article

References (50)

1. Sleijfer S: Bleomycin-induced pneumonitis. Chest 2001, 120:617-624
2. Chua F, Gauldie J, Laurent GJ: Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol 2005, 33:9-13
3. Gharaee-Kermani M, Ullenbruch M, Phan SH: Animal models of pulmonary fibrosis. Methods Mol Med 2005, 117:251-259
4. Garcia JG, James HL, Zinkgraf S, Perlman MB, Keogh BA: Lower respiratory tract abnormalities in rheumatoid interstitial lung disease. Potential role of neutrophils in lung injury. Am Rev Respir Dis 1987, 136:811-817
5. Idell S, Kucich U, Fein A, Kueppers F, James HL, Walsh PN, Weinbaum G, Colman RW, Cohen AB: Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985, 132:1098-1105
6. Hojo S, Fujita J, Yoshinouchi T, Yamanouchi H, Kamei T, Yamadori I, Otsuki Y, Ueda N, Takahara J: Hepatocyte growth factor and neutrophil elastase in idiopathic pulmonary fibrosis. Respir Med 1997, 91:511-516
7. Obayashi Y, Yamadori I, Fujita J, Yoshinouchi T, Ueda N, Takahara J: The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis. Chest 1997, 112:1338-1343
8. Zhang K, Rekhter MD, Gordon D, Phan SH: Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 1994, 145:114-125
9. Broekelmann TJ, Limper AH, Colby TV, McDonald JA: Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991, 88:6642-6646
10. Limper AH, Colby TV, Sanders MS, Asakura S, Roche PC, DeRemee RA: Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 1994, 149:197-204
11. Corrin B, Butcher D, McAnulty BJ, Dubois RM, Black CM, Laurent GJ, Harrison NK: Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology 1994, 24:145-150
12. Khalil N, O'Connor RN, Flanders KC, Unruh H: TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol 1996, 14:131-138
13. Salez F, Gosset P, Copin MC, Lamblin Degros C, Tonnel AB, Wallaert B: Transforming growth factor-beta1 in sarcoidosis. Eur Respir J 1998, 12:913-919
14. Coker RK, Laurent GJ, Jeffery PK, du Bois RM, Black CM, McAnulty RJ: Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung. Thorax 2001, 56:549-556
15. Miyazono K, Olofsson A, Colosetti P, Heldin CH: A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J 1991, 10:1091-1101
16. Hyytiäinen M, Penttinen C, Keski-Oja J: Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 2004, 41:233-264
17. Nunes I, Gleizes PJ, Metz CN, Rifkin DB: Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 1997, 136:1151-1163
18. Taipale J, Koli K, Keski-Oja J: Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem 1992, 267:25378-25384
19. Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J: Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 2000, 12:201-210
20. Campa JS, McAnulty RJ, Laurent GJ: Application of high-pressure liquid chromatography to studies of collagen production by isolated cells in culture. Anal Biochem 1990, 186:257-263
21. Clingen PH, Lowe J, Green MHL: Measurement of DNA damage and repair capacity as a function of age using the comet assay. Aging: Methods and Protocols. Edited by YA Barnet, CR Barnett. Totowa, Humana Press, 2000, pp 143-157
22. Nachlas MM, Margulies SI, Goldberg JD, Seligman AM: The determination of lactic dehydrogenase with a tetrazolium salt. Anal Biochem 1960, 1:317-326
23. Rogers DF, Boschetto P, Barnes PJ: Plasma exudation. Correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo. J Pharmacol Methods 1989, 21:309-315
24. Barcellos-Hoff MH, Ehrhart EJ, Kalia M, Jirtle R, Flanders K, Tsang ML: Immunohistochemical detection of active transforming growth factor-beta in situ using engineered tissue. Am J Pathol 1995, 147:1228-1237
25. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB: An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 1994, 216:276-284
26. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D: The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999, 96:319-328
27. Weinberger SE, Kelman JA, Elson NA, Young Jr RC, Reynolds HY, Fulmer JD, Crystal RG: Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med 1978, 89:459-466
28. Hunninghake GW, Kawanami O, Ferrans VJ, Young Jr RC, Roberts WC, Crystal RG: Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis 1981, 123:407-412
29. Keogh BA, Crystal RG: Alveolitis: the key to the interstitial lung disorders. Thorax 1982, 37:1-10
30. Martin II WJ, Williams DE, Dines DE, Sanderson DR: Interstitial lung disease. Assessment by bronchoalveolar lavage. Mayo Clin Proc 1983, 58:751-757
31. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA: Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med 1984, 310:154-166
32. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA: Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984, 310:235-244
33. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY: Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 1976, 85:769-788
34. Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG: Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1977, 59:165-175
35. Varga J, Jimenez SA: Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-beta. Biochem Biophys Res Commun 1986, 138:974-980
36. Fine A, Goldstein RH: The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem 1987, 262:3897-3902
37. Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, du Bois RM, Jeffery PK, McAnulty RJ: Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 1997, 150:981-991
38. Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ: Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 1997, 29:5-17
39. Diegelmann RF, Evans MC: Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004, 9:283-289
40. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994, 331:1286-1292
41. Giri SN, Hyde DM, Hollinger MA: Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 1993, 48:959-966
42. Giri SN, Hyde DM, Braun RK, Gaarde W, Harper JR, Pierschbacher MD: Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol 1997, 54:1205-1216
43. Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, Iwamoto I: Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999, 104:5-11
44. Wang Q, Wang Y, Hyde DM, Gotwals PJ, Koteliansky VE, Ryan ST, Giri SN: Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters. Thorax 1999, 54:805-812
45. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N: Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998, 93:1159-1170
46. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, Henson PM, Noble PW: Resolution of lung inflammation by CD44. Science 2002, 296:155-158
47. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, Senior RM, Elias JA: Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 2001, 194:809-821
48. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S: Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993, 90:770-774
49. Snider GL, Ciccolella DE, Morris SM, Stone PJ, Lucey EC: Putative role of neutrophil elastase in the pathogenesis of emphysema. Ann NY Acad Sci 1991, 624:45-59
50. O'Connor CM, Gaffney K, Keane J, Southey A, Byrne N, O'Mahoney S, Fitzgerald MX: Alpha 1-proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am Rev Respir Dis 1993, 148:1665-1670